健民集團(600976.SH)擬補充無糖型龍牡壯骨顆粒生產線 改造升級丸劑生產線
格隆匯1月7日丨健民集團(600976.SH)公佈,2020年1月7日,公司第九屆董事會第四次會議審議通過“關於製造中心部分生產線升級改造的議案”,同意公司以自有資金投資1707萬元對製造中心部分生產線進行升級改造。
依據公司產品戰略及營銷規劃,為進一步豐富公司產品線,擬補充一條無糖型龍牡壯骨顆粒生產線,同時改造升級丸劑生產線。公司擬以自有資金投入1707萬元,其中無糖型龍牡壯骨顆粒生產線改造費用1470萬元,丸劑生產線改造費用237萬元;無糖型龍牡壯骨顆粒生產線建設週期150天,丸劑生產線建設週期100天。
無糖型龍牡壯骨顆粒生產線:將現有制粒生產設備改造升級成一步制粒設備;對現有10列、12列條包自動化生產線進行改造;同時引進一條自動包裝線生產線,滿足30袋/盒或60袋/盒的自動聯線生產。項目分兩期實施,一期先對10列/12列包裝設備進行改造,二期2020年依據銷售情況適時啟動全新自動化包裝線購置計劃。
丸劑生產線:拆除原有的二台微波乾燥設備,螺旋乾燥設備。增加二台丸劑乾燥設備;增加糖衣鍋,設置疊丸間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.